|
Fusion gene ID: 12932 |
FusionGeneSummary for FAR2_AGMO |
Fusion gene summary |
Fusion gene information | Fusion gene name: FAR2_AGMO | Fusion gene ID: 12932 | Hgene | Tgene | Gene symbol | FAR2 | AGMO | Gene ID | 55711 | 392636 |
Gene name | fatty acyl-CoA reductase 2 | alkylglycerol monooxygenase | |
Synonyms | HEL-S-81|MLSTD1|SDR10E2 | TMEM195 | |
Cytomap | 12p11.22 | 7p21.2 | |
Type of gene | protein-coding | protein-coding | |
Description | fatty acyl-CoA reductase 2epididymis secretory protein Li 81male sterility domain-containing protein 1short chain dehydrogenase/reductase family 10E, member 2 | alkylglycerol monooxygenaseglyceryl-ether monooxygenasetransmembrane protein 195 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q96K12 | Q6ZNB7 | |
Ensembl transtripts involved in fusion gene | ENST00000536681, ENST00000549080, ENST00000182377, ENST00000547116, | ENST00000342526, ENST00000498264, | |
Fusion gene scores | * DoF score | 2 X 1 X 2=4 | 2 X 1 X 2=4 |
# samples | 2 | 2 | |
** MAII score | log2(2/4*10)=2.32192809488736 | log2(2/4*10)=2.32192809488736 | |
Context | PubMed: FAR2 [Title/Abstract] AND AGMO [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | FAR2 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process | 15220348 |
Tgene | AGMO | GO:0006643 | membrane lipid metabolic process | 20643956 |
Tgene | AGMO | GO:0046485 | ether lipid metabolic process | 20643956 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BLCA | TCGA-KQ-A41Q-01A | FAR2 | chr12 | 29474857 | + | AGMO | chr7 | 15240984 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000536681 | ENST00000342526 | FAR2 | chr12 | 29474857 | + | AGMO | chr7 | 15240984 | - |
5CDS-intron | ENST00000536681 | ENST00000498264 | FAR2 | chr12 | 29474857 | + | AGMO | chr7 | 15240984 | - |
intron-3CDS | ENST00000549080 | ENST00000342526 | FAR2 | chr12 | 29474857 | + | AGMO | chr7 | 15240984 | - |
intron-intron | ENST00000549080 | ENST00000498264 | FAR2 | chr12 | 29474857 | + | AGMO | chr7 | 15240984 | - |
Frame-shift | ENST00000182377 | ENST00000342526 | FAR2 | chr12 | 29474857 | + | AGMO | chr7 | 15240984 | - |
5CDS-intron | ENST00000182377 | ENST00000498264 | FAR2 | chr12 | 29474857 | + | AGMO | chr7 | 15240984 | - |
Frame-shift | ENST00000547116 | ENST00000342526 | FAR2 | chr12 | 29474857 | + | AGMO | chr7 | 15240984 | - |
5CDS-intron | ENST00000547116 | ENST00000498264 | FAR2 | chr12 | 29474857 | + | AGMO | chr7 | 15240984 | - |
Top |
FusionProtFeatures for FAR2_AGMO |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
FAR2 | AGMO |
Catalyzes the reduction of saturated but not unsaturatedC16 or C18 fatty acyl-CoA to fatty alcohols. A lower activity canbe observed with shorter fatty acyl-CoA substrates(PubMed:15220348). It may play a role in the production of etherlipids/plasmalogens and wax monoesters which synthesis requiresfatty alcohols as substrates (By similarity).{ECO:0000250|UniProtKB:Q8WVX9, ECO:0000269|PubMed:15220348}. | Glyceryl-ether monooxygenase that cleaves the O-alkylbond of ether lipids. Ether lipids are essential components ofbrain membranes. {ECO:0000269|PubMed:20643956}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for FAR2_AGMO |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for FAR2_AGMO |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
FAR2 | PEX19, SLC39A4, VSIG4, ERGIC3, IQCF1, ATP2B2, B4GAT1, SCN3B, PCDHGB1, SLC39A12, CHRNA3, VNN2, GRPR | AGMO |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for FAR2_AGMO |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for FAR2_AGMO |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |